Neurocrine Biosciences Shares Promising Results from CAHtalyst Pediatric Study at PES 2025 Annual Meeting Neurocrine Biosciences is set to present significant findings from its Phase 3 CAHtalyst Pediatric study at the upcoming PES 2025 Annual Meeting, showcasing benefits of CRENESSITY.

Neurocrine Biosciences Shares Promising Results from CAHtalyst Pediatric Study at PES 2025 Annual Meeting #United_States #National_Harbor #Crenessity #Neurocrine_Biosciences #CAHtalyst_Study